pWZL Blast myc Citations (20)

Originally described in: Transformation of human and murine fibroblasts without viral oncoproteins.
Boehm JS, Hession MT, Bulmer SE, Hahn WC Mol Cell Biol. 2005 Aug . 25(15):6464-74. PubMed Journal

---

Articles Citing pWZL Blast myc

Articles
K-Ras and B-Raf oncogenes inhibit colon epithelial polarity establishment through up-regulation of c-myc. Magudia K, Lahoz A, Hall A. J Cell Biol. 2012 Jul 23;198(2):185-94. doi: 10.1083/jcb.201202108. PubMed
Constitutive CCND1/CDK2 activity substitutes for p53 loss, or MYC or oncogenic RAS expression in the transformation of human mammary epithelial cells. Junk DJ, Cipriano R, Stampfer M, Jackson MW. PLoS One. 2013;8(2):e53776. doi: 10.1371/journal.pone.0053776. Epub 2013 Feb 4. PubMed
Subcellular localization-dependent changes in EGFP fluorescence lifetime measured by time-resolved flow cytometry. Gohar AV, Cao R, Jenkins P, Li W, Houston JP, Houston KD. Biomed Opt Express. 2013 Jul 19;4(8):1390-400. doi: 10.1364/BOE.4.001390. eCollection 2013. PubMed
Protein and nucleotide biosynthesis are coupled by a single rate-limiting enzyme, PRPS2, to drive cancer. Cunningham JT, Moreno MV, Lodi A, Ronen SM, Ruggero D. Cell. 2014 May 22;157(5):1088-103. doi: 10.1016/j.cell.2014.03.052. PubMed
Androgen receptor (AR) suppresses normal human prostate epithelial cell proliferation via AR/beta-catenin/TCF-4 complex inhibition of c-MYC transcription. Antony L, van der Schoor F, Dalrymple SL, Isaacs JT. Prostate. 2014 Aug;74(11):1118-31. doi: 10.1002/pros.22828. Epub 2014 Jun 9. PubMed
Conversion of androgen receptor signaling from a growth suppressor in normal prostate epithelial cells to an oncogene in prostate cancer cells involves a gain of function in c-Myc regulation. Vander Griend DJ, Litvinov IV, Isaacs JT. Int J Biol Sci. 2014 Jun 10;10(6):627-42. doi: 10.7150/ijbs.8756. eCollection 2014. PubMed
Transcriptional dynamics in colorectal carcinogenesis: new insights into the role of c-Myc and miR17 in benign to cancer transformation. Ben-David E, Bester AC, Shifman S, Kerem B. Cancer Res. 2014 Oct 1;74(19):5532-40. doi: 10.1158/0008-5472.CAN-14-0932. Epub 2014 Aug 14. PubMed
BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene. Sharma N, Magistroni V, Piazza R, Citterio S, Mezzatesta C, Khandelwal P, Pirola A, Gambacorti-Passerini C. Mol Cancer. 2015 Jul 16;14:132. doi: 10.1186/s12943-015-0407-0. PubMed
Xpg limits the expansion of haematopoietic stem and progenitor cells after ionising radiation. Avila AI, Illing A, Becker F, Maerz LD, Morita Y, Philipp M, Burkhalter MD. Nucleic Acids Res. 2016 May 2. pii: gkw376. PubMed
Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth. Hu B, Wang Q, Wang YA, Hua S, Sauve CG, Ong D, Lan ZD, Chang Q, Ho YW, Monasterio MM, Lu X, Zhong Y, Zhang J, Deng P, Tan Z, Wang G, Liao WT, Corley LJ, Yan H, Zhang J, You Y, Liu N, Cai L, Finocchiaro G, Phillips JJ, Berger MS, Spring DJ, Hu J, Sulman EP, Fuller GN, Chin L, Verhaak RG, DePinho RA. Cell. 2016 Nov 17;167(5):1281-1295.e18. doi: 10.1016/j.cell.2016.10.039. PubMed
ERK and p38 MAPK Activities Determine Sensitivity to PI3K/mTOR Inhibition via Regulation of MYC and YAP. Muranen T, Selfors LM, Hwang J, Gallegos LL, Coloff JL, Thoreen CC, Kang SA, Sabatini DM, Mills GB, Brugge JS. Cancer Res. 2016 Dec 15;76(24):7168-7180. Epub 2016 Oct 20. PubMed
Oncogenic Activation of the RNA Binding Protein NELFE and MYC Signaling in Hepatocellular Carcinoma. Dang H, Takai A, Forgues M, Pomyen Y, Mou H, Xue W, Ray D, Ha KCH, Morris QD, Hughes TR, Wang XW. Cancer Cell. 2017 Jul 10;32(1):101-114.e8. doi: 10.1016/j.ccell.2017.06.002. PubMed
Hijacking a key chromatin modulator creates epigenetic vulnerability for MYC-driven cancer. Yang Z, Shah K, Busby T, Giles K, Khodadadi-Jamayran A, Li W, Jiang H. J Clin Invest. 2018 Aug 1;128(8):3605-3618. doi: 10.1172/JCI97072. Epub 2018 Jul 23. PubMed
Identification of the kinase STK25 as an upstream activator of LATS signaling. Lim S, Hermance N, Mudianto T, Mustaly HM, Mauricio IPM, Vittoria MA, Quinton RJ, Howell BW, Cornils H, Manning AL, Ganem NJ. Nat Commun. 2019 Apr 4;10(1):1547. doi: 10.1038/s41467-019-09597-w. PubMed
A Yap-Myc-Sox2-p53 Regulatory Network Dictates Metabolic Homeostasis and Differentiation in Kras-Driven Pancreatic Ductal Adenocarcinomas. Murakami S, Nemazanyy I, White SM, Chen H, Nguyen CDK, Graham GT, Saur D, Pende M, Yi C. Dev Cell. 2019 Oct 7;51(1):113-128.e9. doi: 10.1016/j.devcel.2019.07.022. Epub 2019 Aug 22. PubMed
Biophysical properties of AKAP95 protein condensates regulate splicing and tumorigenesis. Li W, Hu J, Shi B, Palomba F, Digman MA, Gratton E, Jiang H. Nat Cell Biol. 2020 Aug;22(8):960-972. doi: 10.1038/s41556-020-0550-8. Epub 2020 Jul 27. PubMed
Genomic and Functional Regulation of TRIB1 Contributes to Prostate Cancer Pathogenesis. Shahrouzi P, Astobiza I, Cortazar AR, Torrano V, Macchia A, Flores JM, Niespolo C, Mendizabal I, Caloto R, Ercilla A, Camacho L, Arreal L, Bizkarguenaga M, Martinez-Chantar ML, Bustelo XR, Berra E, Kiss-Toth E, Velasco G, Zabala-Letona A, Carracedo A. Cancers (Basel). 2020 Sep 11;12(9). pii: cancers12092593. doi: 10.3390/cancers12092593. PubMed
Revealing molecular pathways for cancer cell fitness through a genetic screen of the cancer translatome. Kuzuoglu-Ozturk D, Hu Z, Rama M, Devericks E, Weiss J, Chiang GG, Worland ST, Brenner SE, Goodarzi H, Gilbert LA, Ruggero D. Cell Rep. 2021 Jun 29;35(13):109321. doi: 10.1016/j.celrep.2021.109321. PubMed
Comprehensive molecular characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation. Quintanal-Villalonga A, Taniguchi H, Zhan YA, Hasan MM, Chavan SS, Meng F, Uddin F, Allaj V, Manoj P, Shah NS, Chan JM, Ciampricotti M, Chow A, Offin M, Ray-Kirton J, Egger JD, Bhanot UK, Linkov I, Asher M, Roehrl MH, Ventura K, Qiu J, de Stanchina E, Chang JC, Rekhtman N, Houck-Loomis B, Koche RP, Yu HA, Sen T, Rudin CM. J Hematol Oncol. 2021 Oct 16;14(1):170. doi: 10.1186/s13045-021-01186-z. PubMed
MYC promotes immune-suppression in triple-negative breast cancer via inhibition of interferon signaling. Zimmerli D, Brambillasca CS, Talens F, Bhin J, Linstra R, Romanens L, Bhattacharya A, Joosten SEP, Da Silva AM, Padrao N, Wellenstein MD, Kersten K, de Boo M, Roorda M, Henneman L, de Bruijn R, Annunziato S, van der Burg E, Drenth AP, Lutz C, Endres T, van de Ven M, Eilers M, Wessels L, de Visser KE, Zwart W, Fehrmann RSN, van Vugt MATM, Jonkers J. Nat Commun. 2022 Nov 2;13(1):6579. doi: 10.1038/s41467-022-34000-6. PubMed

If you have published an article using this material, please email us at to have your article added to this page.